Table of Contents Author Guidelines Submit a Manuscript
Journal of Transplantation
Volume 2011 (2011), Article ID 750836, 9 pages
http://dx.doi.org/10.1155/2011/750836
Clinical Study

BK Virus in Kidney Transplant Recipients: The Influence of Immunosuppression

1Department of Nephrology, University of Queensland at the Princess Alexandra Hospital, Brisbane, QLD 4102, Australia
2School of Pharmacy, University of Queensland, St Lucia, Brisbane, QLD 4072, Australia

Received 14 January 2011; Revised 5 March 2011; Accepted 27 March 2011

Academic Editor: Bernhard K. Krämer

Copyright © 2011 Katherine A. Barraclough et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. U. Meier-Kriesche, J. D. Schold, T. R. Srinivas, and B. Kaplan, “Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era,” American Journal of Transplantation, vol. 4, no. 3, pp. 378–383, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. S. H. Chang, G. R. Russ, S. J. Chadban, S. B. Campbell, and S. P. McDonald, “Trends in kidney transplantation in Australia and New Zealand, 1993–2004,” Transplantation, vol. 84, no. 5, pp. 611–618, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. US Renal Data System, USRDS 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Md, USA, 2006.
  4. S. Hariharan and D. E. Stablein, “Improvements in long-term renal transplant graft survival,” American Journal of Transplantation, vol. 5, no. 3, pp. 630–631, 2005. View at Publisher · View at Google Scholar
  5. J. Ashton-Chess, M. Giral, J. P. Soulillou, and S. Brouard, “Can immune monitoring help to minimize immunosuppression in kidney transplantation?” Transplant International, vol. 22, no. 1, pp. 110–119, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. H. H. Hirsch and J. Steiger, “Polyomavirus BK,” Lancet Infectious Diseases, vol. 3, no. 10, pp. 611–623, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. W. A. Knowles, “Propagation and assay of BK virus,” Methods in Molecular Biology (Clifton, N.J.), vol. 165, pp. 19–31, 2001. View at Google Scholar · View at Scopus
  8. K. V. Shah, R. W. Daniel, and R. M. Warszawski, “High prevalence of antibodies to BK virus, an SV40 related papovavirus, in residents of Maryland,” Journal of Infectious Diseases, vol. 128, no. 6, pp. 784–787, 1973. View at Google Scholar
  9. P. D. Ling, J. A. Lednicky, W. A. Keitel et al., “The dynamics of herpesvirus and polyomavirus reactivation and shedding in healthy adults: a 14-month longitudinal study,” Journal of Infectious Diseases, vol. 187, no. 10, pp. 1571–1580, 2003. View at Publisher · View at Google Scholar
  10. C. Polo, J. L. Pérez, A. Mielnichuck, C. G. Fedele, J. Niubó, and A. Tenorio, “Prevalence and patterns of polyomavirus urinary excretion in immunocompetent adults and children,” Clinical Microbiology and Infection, vol. 10, no. 7, pp. 640–644, 2004. View at Publisher · View at Google Scholar
  11. V. Nickeleit, T. Klimkait, I. F. Binet et al., “Testing for polyomavirus type BK DNA in plasma to identify renal- allograft recipients with viral nephropathy,” New England Journal of Medicine, vol. 342, no. 18, pp. 1309–1315, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. D. L. Bohl and D. C. Brennan, “BK virus nephropathy and kidney transplantation,” Clinical Journal of the American Society of Nephrology, vol. 2, supplement 1, pp. S36–S46, 2007. View at Publisher · View at Google Scholar
  13. H. H. Hirsch, D. C. Brennan, C. B. Drachenberg et al., “Polyomavirus-associated nephropathy in renal transplantation: Interdisciplinary analyses and recommendations,” Transplantation, vol. 79, no. 10, pp. 1277–1286, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. I. Binet, V. Nickeleit, H. H. Hirsch et al., “Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss,” Transplantation, vol. 67, no. 6, pp. 918–922, 1999. View at Google Scholar · View at Scopus
  15. T. Moriyama, K. Namba, and M. Kyo, “Prevalence and characteristics of biopsy-proven BK virus nephropathy in Japanese renal transplant patients: analysis in protocol, non-episode and episode biopsies,” Journal of the American Society of Nephrology, vol. 14, F-PO571, 2003. View at Google Scholar
  16. P. Randhawa and D. C. Brennan, “BK virus infection in transplant recipients: an overview and update,” American Journal of Transplantation, vol. 6, no. 9, pp. 2000–2005, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Ramos, C. B. Drachenberg, J. C. Papadimitriou et al., “Clinical course of polyoma virus nephropathy in 67 renal transplant patients,” Journal of the American Society of Nephrology, vol. 13, no. 8, pp. 2145–2151, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Merlino, M. Bergallo, G. Gribaudo et al., “Polyomavirus BK DNA quantification assay to evaluate viral load in renal transplant recipients,” Journal of Clinical Virology, vol. 28, no. 3, pp. 265–274, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Vasudev, S. Hariharan, S. A. Hussain, Y. R. Zhu, B. A. Bresnahan, and E. P. Cohen, “BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients,” Kidney International, vol. 68, no. 4, pp. 1834–1839, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Mengel, M. Marwedel, J. Radermacher et al., “Incidence of polyomavirus-nephropathy in renal allografts: influence of modern immunosuppressive drugs,” Nephrology Dialysis Transplantation, vol. 18, no. 6, pp. 1190–1196, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. H. H. Hirsch, W. Knowles, M. Dickenmann et al., “Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients,” New England Journal of Medicine, vol. 347, no. 7, pp. 488–496, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Awadalla, P. Randhawa, K. Ruppert, A. Zeevi, and R. J. Duquesnoy, “HLA mismatching increases the risk of BK virus nephropathy in renal transplant recipients,” American Journal of Transplantation, vol. 4, no. 10, pp. 1691–1696, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. D. L. Bohl, G. A. Storch, C. Ryschkewitsch et al., “Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia,” American Journal of Transplantation, vol. 5, no. 9, pp. 2213–2221, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Ginevri, R. De Santis, P. Comoli et al., “Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches,” Transplantation, vol. 75, no. 8, pp. 1266–1270, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. J. M. Smith, R. A. McDonald, L. S. Finn, P. J. Healey, C. L. Davis, and A. P. Limaye, “Polyomavirus nephropathy in pediatric kidney transplant recipients,” American Journal of Transplantation, vol. 4, no. 12, pp. 2109–2117, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Haysom, A. R. Rosenberg, G. Kainer et al., “BK viral infection in an Australian pediatric renal transplant population,” Pediatric Transplantation, vol. 8, no. 5, pp. 480–484, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. C. A. Andrews, R. W. Daniel, and K. V. Shah, “Serologic studies of papovavirus infections in pregnant women and renal transplant recipients,” Progress in clinical and biological research, vol. 105, pp. 133–141, 1983. View at Google Scholar · View at Scopus
  28. C. A. Andrews, K. V. Shah, R. W. Daniel, M. S. Hirsch, and R. H. Rubin, “A serological investigation of BK virus and JC virus infections in recipients of renal allografts,” Journal of Infectious Diseases, vol. 158, no. 1, pp. 176–181, 1988. View at Google Scholar · View at Scopus
  29. P. Comoli, A. Azzi, R. Maccario et al., “Polyomavirus BK-specific immunity after kidney transplantation,” Transplantation, vol. 78, no. 8, pp. 1229–1232, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. M. H. Hammer, G. Brestrich, H. Andree et al., “HLA type-independent method to monitor polyoma BK virus-specific CD4 and CD8 T-cell immunity,” American Journal of Transplantation, vol. 6, no. 3, pp. 625–631, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Chen, J. Trofe, J. Gordon et al., “Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy,” Journal of Virology, vol. 80, no. 7, pp. 3495–3505, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Binggeli, A. Egli, S. Schaub et al., “Polyomavirus BK-specific cellular immune response to VP1 and large T-antigen in kidney transplant recipients,” American Journal of Transplantation, vol. 7, no. 5, pp. 1131–1139, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Ginevri, A. Azzi, H. H. Hirsch et al., “Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients,” American Journal of Transplantation, vol. 7, no. 12, pp. 2727–2735, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. S. E. Prosser, R. J. Orentas, L. Jurgens, E. P. Cohen, and S. Hariharan, “Recovery of BK virus large T-antigen-specific cellular immune response correlates with resolution of BK virus nephritis,” Transplantation, vol. 85, no. 2, pp. 185–192, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. V. R. Dharnidharka, W. S. Cherikh, and K. C. Abbott, “An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United States,” Transplantation, vol. 87, no. 7, pp. 1019–1026, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. A. C. Wiseman, “Polyomavirus nephropathy: a current perspective and clinical considerations,” American Journal of Kidney Diseases, vol. 54, no. 1, pp. 131–142, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Comoli, H. H. Hirsch, and F. Ginevri, “Cellular immune responses to BK virus,” Current Opinion in Organ Transplantation, vol. 13, no. 6, pp. 569–574, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Vahlne, P. A. Larsson, P. Horal et al., “Inhibition of herpes simplex virus production in vitro by Cyclosporin A,” Archives of Virology, vol. 122, no. 1-2, pp. 61–75, 1992. View at Publisher · View at Google Scholar · View at Scopus
  39. C. R. A. Damaso and S. J. Keller, “Cyclosporin A inhibits vaccinia virus replication in vitro,” Archives of Virology, vol. 134, no. 3-4, pp. 303–319, 1994. View at Google Scholar · View at Scopus
  40. E. K. Franke and J. Luban, “Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction,” Virology, vol. 222, no. 1, pp. 279–282, 1996. View at Publisher · View at Google Scholar · View at Scopus
  41. M. A. Wainberg, A. Dascal, N. Blain et al., “The effect of cyclosporine A on infection of susceptible cells by human immunodeficiency virus type 1,” Blood, vol. 72, no. 6, pp. 1904–1910, 1988. View at Google Scholar
  42. K. Watashi, M. Hijikata, M. Hosaka, M. Yamaji, and K. Shimotohno, “Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes,” Hepatology, vol. 38, no. 5, pp. 1282–1288, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. S. D. Henry, H. J. Metselaar, R. C. B. Lonsdale et al., “Mycophenolic acid inhibits hepatitis C virus replication and acts in synergy with cyclosporin A and interferon-α,” Gastroenterology, vol. 131, no. 5, pp. 1452–1462, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Nakagawa, N. Sakamoto, N. Enomoto et al., “Specific inhibition of hepatitis C virus replication by cyclosporin A,” Biochemical and Biophysical Research Communications, vol. 313, no. 1, pp. 42–47, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. R. J. Firpi, H. Zhu, G. Morelli et al., “Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation,” Liver Transplantation, vol. 12, no. 1, pp. 51–57, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Neyts and E. De Clercq, “The immunosuppressive agent mycophenolate mofetil markedly potentiates the activity of lobucavir [1R(1α,2β,3α)]-9-[2,3-bis(hydroxymethyl)- cyclobutyl]guanine against different herpes viruses,” Transplantation, vol. 67, no. 5, pp. 760–764, 1999. View at Google Scholar · View at Scopus
  47. A. G. Chapuis, G. P. Rizzardi, C. D'Agostino et al., “Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo,” Nature Medicine, vol. 6, no. 7, pp. 762–768, 2000. View at Publisher · View at Google Scholar · View at Scopus
  48. M. M. Hossain, J. J. Coull, G. L. Drusano, and D. M. Margolis, “Dose proportional inhibition of HIV-1 replication by mycophenolic acid and synergistic inhibition in combination with abacavir, didanosine, and tenofovir,” Antiviral Research, vol. 55, no. 1, pp. 41–52, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. R. Kaur, V. Klichko, and D. Margolis, “Ex vivo modeling of the effects of mycophenolic acid on HIV infection: considerations for antiviral therapy,” AIDS Research and Human Retroviruses, vol. 21, no. 2, pp. 116–124, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Wu, H. Y. Xie, G. P. Jiang, X. Xu, and S. S. Zheng, “The effect of mycophenolate acid on hepatitis B virus replication in vitro,” Hepatobiliary and Pancreatic Diseases International, vol. 2, no. 3, pp. 410–413, 2003. View at Google Scholar · View at Scopus
  51. C. Ying, E. De Clercq, and J. Neyts, “Ribavirin and mycophenolic acid potentiate the activity of guanine- and diaminopurine-based nucleoside analogues against hepatitis B virus,” Antiviral Research, vol. 48, no. 2, pp. 117–124, 2000. View at Publisher · View at Google Scholar · View at Scopus
  52. Z. J. Gong, S. De Meyer, C. Clarysse et al., “Mycophenolic acid, an immunosuppressive agent, inhibits HBV replication in vitro,” Journal of Viral Hepatitis, vol. 6, no. 3, pp. 229–236, 1999. View at Publisher · View at Google Scholar · View at Scopus
  53. P. D. Acott, P. A. O'Regan, S. H. Lee, and J. F. S. Crocker, “In vitro effect of cyclosporin A on primary and chronic BK polyoma virus infection in Vero E6 cells,” Transplant Infectious Disease, vol. 10, no. 6, pp. 385–390, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. P. Acott, P. A. O'Regan, and J. F. S. Crocker, “Suppression of early and chronic BK polyoma virus replication by mycophenolic acid in Vero cells,” Transplant International, vol. 22, no. 2, pp. 225–231, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. YI. J. Li, C. H. Weng, W. C. Lai et al., “A Suppressive effect of cyclosporine A on replication and noncoding control region activation of polyomavirus BK virus,” Transplantation, vol. 89, no. 3, pp. 299–306, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Liacini, M. E. Seamone, D. A. Muruve, and L. A. Tibbles, “Anti-BK virus mechanisms of sirolimus and leflunomide alone and in combination: toward a new therapy for BK virus infection,” Transplantation, vol. 90, no. 12, pp. 1450–1457, 2010. View at Publisher · View at Google Scholar
  57. U. Moens, N. Subramaniam, B. Johansen, T. Johansen, and T. Traavik, “A steroid hormone response unit in the late leader of the noncoding control region of the human polyomavirus BK confers enhanced host cell permissivity,” Journal of Virology, vol. 68, no. 4, pp. 2398–2408, 1994. View at Google Scholar · View at Scopus
  58. A. Egli, S. Köhli, M. Dickenmann, and H. H. Hirsch, “Inhibition of polyomavirus BK-specific t-cell responses by immunosuppressive drugs,” Transplantation, vol. 88, no. 10, pp. 1161–1168, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. Y. M. Barri, I. Ahmad, B. L. Ketel et al., “Polyoma viral infection in renal transplantation: the role of immunosuppressive therapy,” Clinical Transplantation, vol. 15, no. 4, pp. 240–246, 2001. View at Publisher · View at Google Scholar · View at Scopus
  60. V. Nickeleit, H. H. Hirsch, I. F. Binet et al., “Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease,” Journal of the American Society of Nephrology, vol. 10, no. 5, pp. 1080–1089, 1999. View at Google Scholar · View at Scopus
  61. O. Prince, S. Savic, M. Dickenmann, J. Steiger, L. Bubendorf, and M. J. Mihatsch, “Risk factors for polyoma virus nephropathy,” Nephrology Dialysis Transplantation, vol. 24, no. 3, pp. 1024–1033, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. M. Koukoulaki, E. Grispou, D. Pistolas et al., “Prospective monitoring of BK virus replication in renal transplant recipients,” Transplant Infectious Disease, vol. 11, no. 1, pp. 1–10, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. M. S. Sachdeva, R. Nada, V. Jha, V. Sakhuja, and K. Joshi, “The high incidence of BK polyoma virus infection among renal transplant recipients in India,” Transplantation, vol. 77, no. 3, pp. 429–431, 2004. View at Publisher · View at Google Scholar · View at Scopus
  64. F. G. Cosio, H. Amer, J. P. Grande, T. S. Larson, M. D. Stegall, and M. D. Griffin, “Comparison of low versus high tacrolimus levels in kidney transplantation: assessment of efficacy by protocol biopsies,” Transplantation, vol. 83, no. 4, pp. 411–416, 2007. View at Publisher · View at Google Scholar · View at Scopus
  65. A. Haririan, O. Hamze, C. B. Drachenberg, E. Ramos, M. R. Weir, and D. K. Klassen, “Polyomavirus reactivation in native kidneys of pancreas alone allograft recipients,” Transplantation, vol. 75, no. 8, pp. 1186–1190, 2003. View at Publisher · View at Google Scholar · View at Scopus
  66. W. Manitpisitkul, C. Drachenberg, E. Ramos et al., “Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: a case-control study,” Transplantation, vol. 88, no. 1, pp. 83–88, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. D. Dadhania, C. Snopkowski, R. Ding et al., “Epidemiology of BK virus in renal allograft recipients: independent risk factors for bk virus replication,” Transplantation, vol. 86, no. 4, pp. 521–528, 2008. View at Publisher · View at Google Scholar · View at Scopus
  68. W. Manitpisitkul, N. S. Wilson, and A. Haririan, “Immunosuppressive agents as risk factors for BK virus nephropathy: an overview and update,” Expert Opinion on Drug Safety, vol. 9, no. 6, pp. 959–969, 2010. View at Publisher · View at Google Scholar
  69. P. Wallemacq, V. W. Armstrong, M. Brunet et al., “Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the european consensus conference,” Therapeutic Drug Monitoring, vol. 31, no. 2, pp. 139–152, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. K. A. Barraclough, C. E. Staatz, N. M. Isbel, and D. W. Johnson, “Therapeutic monitoring of mycophenolate in transplantation: is it justified?” Current Drug Metabolism, vol. 10, no. 2, pp. 179–187, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. J. M. Morton, S. Williamson, L. M. Kear, B. C. McWhinney, J. Potter, and A. R. Glanville, “Therapeutic drug monitoring of prednisolone after lung transplantation,” Journal of Heart and Lung Transplantation, vol. 25, no. 5, pp. 557–563, 2006. View at Publisher · View at Google Scholar · View at Scopus
  72. J. M. Potter, B. C. McWhinney, L. Sampson, and P. E. Hickman, “Area-under-the-curve monitoring of prednisolone for dose optimization in a stable renal transplant population,” Therapeutic Drug Monitoring, vol. 26, no. 4, pp. 408–414, 2004. View at Publisher · View at Google Scholar · View at Scopus
  73. D. C. Brennan, I. Agha, D. L. Bohl et al., “Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction,” American Journal of Transplantation, vol. 5, no. 3, pp. 582–594, 2005. View at Publisher · View at Google Scholar · View at Scopus
  74. F. Vincenti, S. Friman, E. Scheuermann et al., “Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus,” American Journal of Transplantation, vol. 7, no. 6, pp. 1506–1514, 2007. View at Publisher · View at Google Scholar · View at Scopus
  75. J Trofe, P Roy-Chaudhury, J Gordon et al., “Early steroid cessation/avoidance regimens are associated with a lower Incidence of polyomavirus nephropathy compared to steroid based immunosuppression in kidney transplant recipeints (Abstract #856),” American Journal of Transplantation, vol. 3, supplement 5, p. 371, 2003. View at Google Scholar
  76. G. S. Lipshutz, S. M. Flechner, M. V. Govani, and F. Vincenti, “BK nephropathy in kidney transplant recipients treated with a calcineurin inhibitor-free immunosuppression regimen,” American Journal of Transplantation, vol. 4, no. 12, pp. 2132–2134, 2004. View at Publisher · View at Google Scholar · View at Scopus
  77. C. A. Benavides, V. B. Pollard, S. Mauiyyedi, H. Podder, R. Knight, and B. D. Kahan, “BK virus-associated nephropathy in sirolimus-treated renal transplant patients: incidence, course, and clinical outcomes,” Transplantation, vol. 84, no. 1, pp. 83–88, 2007. View at Publisher · View at Google Scholar · View at Scopus
  78. A. Vats, R. Shapiro, P. S. Randhawa et al., “Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults,” Transplantation, vol. 75, no. 1, pp. 105–112, 2003. View at Publisher · View at Google Scholar · View at Scopus
  79. C. E. Araya, J. F. Lew, R. S. Fennell, R. E. Neiberger, and V. R. Dharnidharka, “Intermediate dose cidofovir does not cause additive nephrotoxicity in BK virus allograft nephropathy,” Pediatric Transplantation, vol. 12, no. 7, pp. 790–795, 2008. View at Publisher · View at Google Scholar · View at Scopus
  80. A. Sener, A. A. House, A. M. Jevnikar et al., “Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: one-year follow-up of renal allograft recipients,” Transplantation, vol. 81, no. 1, pp. 117–120, 2006. View at Publisher · View at Google Scholar · View at Scopus
  81. J. W. Williams, B. Javaid, P. V. Kadambi et al., “Leflunomide for polyomavirus type BK nephropathy,” New England Journal of Medicine, vol. 352, no. 11, pp. 1157–1158, 2005. View at Publisher · View at Google Scholar · View at Scopus
  82. H. H. Hirsch and P. Randhawa, “BK virus in solid organ transplant recipients,” American Journal of Transplantation, vol. 9, no. 4, pp. S136–S146, 2009. View at Publisher · View at Google Scholar · View at Scopus
  83. O. Johnston, D. Jaswal, J. S. Gill, S. Doucette, D. A. Fergusson, and G. A. Knoll, “Treatment of polyomavirus infection in kidney transplant recipients: a systematic review,” Transplantation, vol. 89, no. 9, pp. 1057–1070, 2010. View at Publisher · View at Google Scholar · View at Scopus
  84. J. Trofe, T. Cavallo, M. R. First et al., “Polyomavirus in kidney and kidney-pancreas transplantation: a defined protocol for immunosuppression reduction and histologic monitoring,” Transplantation Proceedings, vol. 34, no. 5, pp. 1788–1789, 2002. View at Publisher · View at Google Scholar · View at Scopus
  85. P. S. Randhawa, A. Vats, D. Zygmunt et al., “Quantitation of viral DNA in renal allograft tissue from patients with BK virus nephropathy,” Transplantation, vol. 74, no. 4, pp. 485–488, 2002. View at Google Scholar · View at Scopus
  86. K. A. Barraclough, C. E. Staatz, N. M. Isbel, and S. J. McTaggart, “Review: pharmacodynamic monitoring of immunosuppression in kidney transplantation,” Nephrology, vol. 15, no. 5, pp. 522–532, 2010. View at Publisher · View at Google Scholar